Eye-catching Brilliant Violet 421™ Anti-human Cd340 (erbb2/her-2) Price Crushed By 65% [ZKO20L9r]

Brilliant Violet 421™ Anti-human CD340 (erbB2/HER-2)

The Eye-catching Brilliant Violet 421™ Anti-human Cd340 (erbb2/her-2) Price Crushed By 65% [ZKO20L9r] is a powerful monoclonal antibody designed for the detection of human CD340, also known as HER2/erbB2. This antibody is a valuable tool for researchers studying cancer progression and embryonic development. With its high specificity and sensitivity, it allows for accurate and reliable analysis of CD340 expression in various tumor types, including breast, lung, gastric, ovarian, and glioblastoma.

Product Specifications and Features

This antibody is produced using the 24D2 clone and is of mouse origin. It is formatted in BV421, a vibrant fluorescent dye that enhances the visibility of your samples under flow cytometry. The antibody recognizes the extracellular region of CD340, which contains three furin repeats and two cheY homologous receiver domains. Key features include a high affinity for human CD340, extensive tyrosine phosphorylation, and the ability to form heterodimers with other EGF receptor family members.

• High specificity for human CD340
• Recognizes extracellular region of CD340
• Extensive tyrosine phosphorylation sites

Applications and Benefits

The Eye-catching Brilliant Violet 421™ Anti-human Cd340 (erbb2/her-2) Price Crushed By 65% [ZKO20L9r] is suitable for flow cytometry and can be used in various research applications. Its ability to detect CD340 expression makes it ideal for studies on cancer progression, especially in breast cancer where erbB2 overexpression is linked to Taxol resistance. This antibody is also valuable for investigating the role of CD340 in embryonic development and its interaction with a wide range of proteins, including SHC1, EGF receptor, and c-Src. By using this antibody, researchers can gain deeper insights into the complex mechanisms of cell signaling and oncogenesis.

• Flow cytometry applications
• Studying cancer progression and embryonic development
• Understanding CD340 protein interactions